(MENAFN- GlobeNewsWire - Nasdaq) Through enhanced cognitive screening via CANTABTM, the partnership aims to accelerate clinical trial recruitment for CNS studies.
Wauwasota, WI, and Cambridge, UK, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Splash Clinical , the new standard in patient recruitment solutions, and Cambridge Cognition (AIM: COG), a leading provider of digital health solutions for brain health assessments, announced today a partnership to accelerate recruitment for central nervous system (CNS) clinical trials.
The collaboration between Splash Clinical and Cambridge Cognition integrates CANTAB (Cambridge Neuropsychological Test Automated Battery), Cambridge Cognition's proprietary assessment tool, into Splash's patient recruitment platform, facilitating the pre-screening process for clinical trial candidates for studies focusing on CNS indications.
"We're thrilled to partner with Cambridge Cognition," said Matt Teuteberg, Founder and CEO of Splash Clinical. "By integrating their assessment tools into our platform, we will increase our efficiency in finding the right patients for clinical trials. This partnership will save time and resources for our clients and ultimately make treatments available for patients faster."
By integrating CANTAB early in the recruitment process, the partnership will significantly improve patient qualification. At the same time, it reduces screening failures and increases the quality of patients entering the trial. Potential trial participants can complete the online cognitive assessment in 5-10 minutes, providing researchers with critical pre-screening data before in-person visits. By building upon Splash Clinical's recruitment methods. Researchers will be able to reach a broader population while maintaining high-quality standards.
"Partnering with Splash just made sense for us," said Liam Kaufman, Cambridge Cognition's VP of Clinical Sciences. "They've got a great recruitment platform and a solid track record in recruitment. Our tools complement their process perfectly. Our goal is to make it easier for researchers to find the right participants for their CNS trials. It's a win-win for everyone involved."
CANTAB's integration into Splash's platform was successfully tested last year. During the pilot, Cambridge Cognition's software helped to filter in hard-to-find patients with early Alzheimer's symptoms. Results from the test showed a significant reduction in screen failures and an increase in the quality of participants entering the trial. Based on these promising results, Splash Clinical and Cambridge Cognition are expanding their collaboration to benefit researchers, sponsors, and patients across various CNS indications.
About Splash Clinical
Splash Clinical is the new standard in patient recruitment solutions. We transform recruitment processes, setting a new benchmark for the industry. Combining the powers of digital media, mobile technologies, social media, and real-time analytics, our unique recruiting methodology has successfully expedited enrollment for clinical studies worldwide.
Splash Clinical delivers precision-targeted patient recruitment strategies, meeting the unique demands of Sponsors, Contract Research Organizations (CROs), and Sites. We ensure that our partners can focus on the vital task of advancing medical research while we take care of securing high-quality patient referrals for each study. With transparency embedded into our approach, we provide clients with real-time performance insights, stripping the recruitment landscape of any surprises.
While we employ cutting-edge digital solutions, our real edge comes from our people-centric approach. At the heart of Splash Clinical is a team that goes above and beyond to understand our clients' needs, providing a level of service that sets us apart from the competition. As a result, we deliver personalized services and foster strong relationships in the pursuit of accelerating clinical research to improve human health.
Splash Clinical was founded in 2011 and is proudly based in Wauwatosa, WI. To learn more, please visit .
Splash Clinical. Redefining Patient Recruitment.
About Cambridge Cognition
Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in the pharmaceutical and healthcare industries.
For more about Cambridge Cognition's digital health solutions, visit
CONTACT: Juan Avila
Splash Clinical
...
Annabelle Miles
Cambridge Cognition
...
MENAFN06092024004107003653ID1108645476
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.